Blue Ox Healthcare Partners

Blue Ox Healthcare Partners is a private equity investment firm that provides capital to growth-stage healthcare companies. It focuses on businesses in the middle market targeting the industry’s transformation to individuality and value-based care in healthcare services, HCIT, and medical and life sciences technologies, whose innovations, strategies, and operations are poised for growth. The firm has invested in a range of companies where its extensive healthcare industry, investment, and operational expertise can be leveraged to a company’s long-term benefit since 2009.

Levy, Oded

Managing Partner

John A. Neczesny

Managing Partner, COO and Member of Investment Committee

Alexander Rogers

Principal

8 past transactions

Epic Sciences

Series G in 2023
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

Gemelli Biotech

Series A in 2022
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics. It strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. The company is driven by its mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringing biotechnology innovations to market in a fiscally responsible and socially conscious way. The company was founded in 2018 and headquartered in North Carolina, United States.

Epic Sciences

Series F in 2022
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

Sera Prognostics

Series E in 2021
Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the prediction of preterm birth risk and other complications of pregnancy. Sera’s PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk.

Sera Prognostics

Series D in 2019
Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the prediction of preterm birth risk and other complications of pregnancy. Sera’s PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk.

Epic Sciences

Series E in 2018
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

RX Solutions

Private Equity Round in 2018
RX Solutions which helps lower-income people gain access to fixed and/or reduced cost prescription drugs. RX Solutions serves consumers by identifying Prescription Assistance Programs (“PAPs”) specific to their medication needs and then follows them throughout the process to secure the subsidies and medications.

Infinity Behavioral Health Services

Private Equity Round in 2015
Infinity Behavioral Health Services, we offer a variety of services meant to provide clients with the assistance necessary to take their business to the next level. e are aware that treating your patients is job number one. While you are helping others, we are doing our part to bring in revenue from third-party insurance companies. Our job is to help take the stress and uncertainty out of your insurance revenue so you can focus on doing what you do best.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.